Observations placeholder
Serentil
Identifier
020028
Type of Spiritual Experience
Number of hallucinations: 3
Background
A description of the experience
Mesoridazine (Serentil) is a piperidine neuroleptic drug belonging to the class of drugs called phenothiazines, used in the treatment of schizophrenia. It is a metabolite of thioridazine. The drug's name is derived from the methylsulfoxy and piperidine functional groups in its chemical structure.
It has central antiadrenergic, antidopaminergic, antiserotonergic and weak muscarinic anticholinergic effects.
Serious side effects include akathisia, tardive dyskinesia and the potentially fatal neuroleptic malignant syndrome.
Mesoridazine was withdrawn from the United States market in 2004 due to dangerous side effects, namely irregular heart beat and QT-prolongation of the electrocardiogram
It currently appears to be unavailable worldwide.
On Feb, 8, 2016: 137 people reported to have side effects when taking Serentil. Among them, 3 people (2.19%) have Hallucination.
On Feb, 8, 2016: 137 people reported to have side effects when taking Serentil. Among them, 3 people (2.19%) have Death.
Time on Serentil when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 66.67% | 33.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Serentil :
| Female | Male | |
| Death | 33.33% | 66.67% |
Age of people who have Death when taking Serentil :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% |